DOI QR코드

DOI QR Code

Review of Randomized Controlled Trials Research of Gyejibongnyeong-hwan and Gyejibongnyeong-hwan gagam for Chronic Pelvic Inflammatory Disease

만성 골반 염증성 질환의 계지복령환 및 계지복령환 가감방 투여에 대한 중의학 연구 동향 : 무작위 대조군 임상 연구를 중심으로

  • Yeon-Soo Jung (Graduate School of Korean Medicine, Pusan National University) ;
  • Young-Jin Yoon (Dept. of Korean Medicine Obstetrics & Gynecology, Graduate School of Korean Medicine, Pusan National University) ;
  • Hee-Yoon Lee (Dept. of Korean Medicine Obstetrics & Gynecology, Pusan National University Korean Medicine Hospital) ;
  • Jang-Kyung Park (Dept. of Korean Medicine Obstetrics & Gynecology, Graduate School of Korean Medicine, Pusan National University)
  • 정연수 (부산대학교 한의학전문대학원) ;
  • 윤영진 (부산대학교 한의학전문대학원 한방부인과) ;
  • 이희윤 (부산대학교 한방병원) ;
  • 박장경 (부산대학교 한의학전문대학원 한방부인과)
  • Received : 2023.07.07
  • Accepted : 2023.08.25
  • Published : 2023.08.25

Abstract

Objectives: The purpose of this study is to review the trends of clinical trials of traditional herbal medicine Gyejibongnyeong-hwan for chronic pelvic inflammatory disease in CNKI. Methods: We searched relevant studies using Chinese National Knowledge Infrastructure (CNKI). Data retrieval was carried out by December 20th, 2021. We analyzed characteristics of study subjects, treatment period, composition of prescription, outcome and adverse event of selected studies and the risk of bias was assessed by using Cochrane's risk of bias tool. Results: Among the total 988 studies, 10 studies met the inclusion criteria. All of the studies were randomized controlled studies and written in Chinese. In all studies, Gyejibongnyeong-hwan was effective in improving chronic pelvic inflammatory disease. Conclusions: This study suggests that Gyejibongnyeong-hwan can be effective in treating chronic pelvic inflammatory disease compared to antibiotics treatment. Further large and well-established randomized placebo controlled trials will be needed.

Keywords

Acknowledgement

본 연구는 2023년도 부산대학교병원 임상 연구비 지원으로 이루어졌음

References

  1. Korean Society of Obstetrics and Gynecology. Gynecology. 6th ed. Seoul: Koonja Publishing Inc. 2021:150-2. 
  2. Shin JS, et al. Leukocystes and Lactobacilli of Vaginal Discharge as A Predictor of Pelvic Inflammatory Disease. Korean Journal of Obstetrics & Gynecology. 2007;50(9):1247-53. 
  3. Curry A, Williams T, Penny ML. Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. Am Fam Physician. 2019;100(6):357-64. 
  4. Haggerty CL, Taylor BD. Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease. Infectious diseases in obstetrics and gynecology. 2011;2011:959816. 
  5. Larsen B, Hwang J. Mycoplasma, Ureaplasma, and Adverse Pregnancy Outcomes: A Fresh Look. Infectious Diseases in Obstetrics and Gynecology. 2010;2010:521921. 
  6. The Society of Korean Medicine Obstetrics and Gynecology. Manual of Korean Medicine Obstetrician and Gynecologist. Seoul:Euiseongdang. 2017:811. 
  7. Lee EK, et al. A Clinical Report on Two Patients with Chronic Pelvic Inflammatory Disease. The Journal of Korean Obstetrics and Gynecology. 2018;31(3):109-20.  https://doi.org/10.15204/JKOBGY.2018.31.3.109
  8. Frock-Welnak DN, Tam J. Identification and Treatment of Acute Pelvic Inflammatory Disease and Associated Sequelae. Obstet Gynecol Clin North Am. 2022;49(3):551-79.  https://doi.org/10.1016/j.ogc.2022.02.019
  9. Cho MK. Update on the management of pelvic inflammatory disease. Korean Journal of Obstetrics and Gynecology. 2010;53(11):961-6.  https://doi.org/10.5468/kjog.2010.53.11.961
  10. Si TY, Yang JL. Clinical Treatment of Gynecology Specialty Diseases in Traditional Chinese Medicine(婦科專病中醫臨床論治). Beijing:People's Health Publishing House. 2001:224-64. 
  11. Choi MS, et al. A study on diagnosis and cooperative medical treatment between oriental and western medicine of pelvic inflammatory disease(PID) ; A case report of pyosalpinx misdiagnosed as a internal medical disease. The Society of Korean Medicine Obstetrics and Gynecology. 2003;16(3):217-26. 
  12. Kim JH, Lee TG. Literature Study on Pelvic Inflammatory Disease. The Journal of Korean Obstetrics and Gynecology. 1994;7(1):31-46. 
  13. Kwon DY. Translation with Prescriptions of the Golden Chamber. Bundang: Seonbosa. 2002:471. 
  14. Cho JH. A pilot study of the difference between Gyejibongnyeong-hwan and Gyejibongnyeong-hwan combined acupuncture therapy on the primary dysmenorrhea. The Journal of oriental obstetrics & gynecology. 2007;20(1):161-8. 
  15. Kang S, et al. Case Report of Treating Ovarian Cysts with Guizhi Fuling-hwan. The Journal of oriental gynecology. 2000;13(2):399-406. 
  16. Lee SH, et al. A Case Report of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) treated with Gyejibokryeong-hwan. Journal of Korean Medicine. 2020;41(1):117-25.  https://doi.org/10.13048/jkm.20009
  17. Ke Z, et al. Study of effective components and molecular mechanism for Guizhi Fuling formula treatment of dysmenorrhea, pelvic inflammatory disease and uterine fibroids. China Journal of Chinese Materia Medica. 2015;40(6):999-1004. 
  18. Ban HR, Lee JA, Cho SH. A case of Chronic Pelvic Inflammatory Disease. The Journal of oriental obstetrics & gynecology. 2005;18(1):253-61. 
  19. Yun MJ, Yoo DY. Clinical report on a patient with chronic PID. Journal of Haehwa Medicine. 2012;21(1):109-15. 
  20. Rho EJ, Ahn SY, Kim DC. Review of Randomized Controlled Trials of Traditional Herbal Medicine for Chronic Pelvic Inflammatory Disease. The Journal of Oriental Gynecology. 2021;34(4):46-61. 
  21. Ge SQ, Liu L. Clinical Analysis of the Treatment of Chronic Pelvic Inflammatory Disease with Modified Guizhi Fuling Decoction(桂枝茯苓汤加减治疗慢性盆腔炎临床分析). China Practical Medicine. 2007;2(12):80. 
  22. Pang XR. Cases of Chronic Pelvic Inflammatory Disease Treated in Modified Ramulus Cinnaomoni and Hoelen Pills. Journal of Henan University of Chinese medicine. 2009;24(141):67-8. 
  23. Liu YX, Study on the clinical effect of Cinnamon Twig and Poria Decoction in chronic pelvic inflammation. China Modern Medicine. 2012;19(26):124-5. 
  24. Wang ZQ, Analysis of 30 cases of therapeutic effect of Guizhi Fuling Pill in the treatment of chronic pelvic inflammatory disease. World Latest Medicine Information. 2015;15(2):19-20. 
  25. Chen JH, Wu LL. Clinical Study of Guizhi Fuling Pill in the Treatment of Chronic Pelvic Inflammatory Disease. China and Foreign Medical Treatment. 2016;2016(36):166-8.  https://doi.org/10.4236/cm.2016.74016
  26. Wang JY. A Research Study of Efficacy of Modified Guizhi Fuling-tang in the Treatment of Chronic Pelvic Inflammatory Disease(桂枝茯苓汤加减治疗慢性盆腔炎的效果研究). World Latest Medicine Information. 2016;16(105):171. 
  27. Zhao HM. Clinical Analysis on Guizhifuling Pill the Addition and Subtraction in the Treatment of Chronic Pelvic Inflammatory Disease. China Health Standard Management. 2016;7(9):135-6. 
  28. Cai M, Wang L, Liu YH. Effect of Guizhi Fuling Capsule on patients with chronic pelvic inflammatory disease and the change of IL-8, ICAM-1, MMP-2. Chinese Archives of Traditional Chinese Medicine. 2020:1-7. Available from:URL:https://kns.cnki.net/kcms/detail/21.1546.R.20201202.1721.044.html. 
  29. Qin JJ. Curative effect of Guizhi Fuling Pill on chronic pelvic inflammation. Chinese Manipulation and Rehabilitation Medicine. 2020;11(18):46-7. 
  30. Xia T. Clinical effect of Guizhi Fuling Decoction on chronic pelvic inflammatory disease. Journal of Liaoning University of Traditional Chinese Medicine. 2021:1-8. Available from:URL:https://kns.cnki.net/kcms/detail/21.1543.R.20210510.1438.002.html  10510.1438.002.html
  31. Koh JW, Lee ES. The Efficacy of 1.5mg Single Oral Metronidazole Dose in the Treatment of Trichomoniasis. Inje Medical Journal. 1999;20(1):337-47. 
  32. Herbal formula science in Korean medicine. Committee for the Textbook of Traditional Korean Prescription. Seoul:Younglim publish house. 2003:409. 
  33. Jang SB, et al. The Analysis of the Experimental Research Trend of Efficacy of Gyejibokryeong-hwan. Journal of Korean Obstet Gynecol. 2016;29(2):99-112.  https://doi.org/10.15204/jkobgy.2016.29.2.099
  34. Ji QH. Application of Modified Guizhi Fuling Pills in Gynecological Diseases (桂枝茯苓丸加减在妇科病中的应用). Asia-Pacific Traditional Medicine. 2011;7(5):45. 
  35. Miettinen AK, et al. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. American journal of obstetrics and gynecology. 1993;169(5):1143-9.  https://doi.org/10.1016/0002-9378(93)90271-J
  36. Sjowall C. C-reactive protein (CRP) and anti-CRP autoantibodies in systemic lupus erythematosus. Department of Molecular and Clinical Medicine, Graduate School, Linkoping University. 2006. 
  37. Matalliotakis IM, et al. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. Journal of Reproductive Immunology. 2001;51(1):9-19.  https://doi.org/10.1016/S0165-0378(01)00064-X
  38. Zhang H, Liu R. Study of immunoregulation of T cell subset and red cell immunology on chronic pelvic inflammatory disease rats treated by Guizhifuling Capsule. Pharmacology and Clinics of Chinese Materia Medica. 2013;29(2):6-8. 
  39. Chen KS, et al. Significant elevation of a Th2 cytokine, interleukin-10, in pelvic inflammatory disease. Clinical Chemistry and Laboratory Medicine. 2008;46(11):1609-16.  https://doi.org/10.1515/CCLM.2008.318
  40. Kwon SB, et al. Antibiotics-associated Diarrhea and Other Gastrointestinal Abnormal Responses Regarding Helicobacter pylori Eradication. The Korean Journal of Gastroenterology. 2010;56(4):229-35.  https://doi.org/10.4166/kjg.2010.56.4.229
  41. Qin CM, et al. Effects of active components in compatible solution of Sparganii Rhizoma-Curcumae Rhizoma on pelvic adhesion in rats with chronic pelvic inflammatory disease. Chinese Traditional Patent Medicine. 2018;40(6):1233-7. 
  42. Xie Y, Wang S, Guo Q. Experimental study on anti-inflammatory function of hirudo. Journal of the Fourth Military Medical University. 1996;17(6):431-3. 
  43. Wu QG, et al. Study on Analgesic Activity of Corydalis yanhusuo Based on Network Pharmacology. Journal of Yichun University. 2022;44(6):18-24. 
  44. Kim BJ, et al. Inhibitory Effect of Extract of Trogopterorum Faeces on the Production of Inflammatory Mediaters. Korean Journal of Herbology. 2009;24(3):153-60.